I agree that this site is using cookies. You can find further informations here.
X
Kawalec, P
103  results:
Search for persons X
?
1

CO70 Comparative Bayesian Network Meta-Analysis of BTKi-Spe..:

Monica, M. ; Reczek, M. ; Kawalec, P.
Value in Health.  27 (2024)  6 - p. S29-S30 , 2024
Link: https://doi.org/10.1016/..
 
?
2

EE550 Lifetime Cost of Orphan Therapies in Paediatric Indic..:

Wex, J. ; Holko, P. ; Kawalec, P..
Value in Health.  26 (2023)  12 - p. S158 , 2023
Link: https://doi.org/10.1016/..
 
?
3

CO72 Risk of Richter Transformation in Relapsed/Refractory ..:

Monica, M. ; Reczek, M. ; Kawalec, P.
Value in Health.  26 (2023)  6 - p. S27-S28 , 2023
Link: https://doi.org/10.1016/..
 
?
4

CO112 Efficacy and Safety of Venetoclax+Rituximab in the Tr..:

Monica, M. ; Reczek, M. ; Kawalec, P.
Value in Health.  26 (2023)  6 - p. S35 , 2023
Link: https://doi.org/10.1016/..
 
?
5

CO182 Efficacy of Venetoclax+Obinutuzumab+Ibrutinib Compare..:

Stożek-Tutro, A. ; Reczek, M. ; Kawalec, P.
Value in Health.  26 (2023)  12 - p. S46 , 2023
Link: https://doi.org/10.1016/..
 
?
6

HTA168 Data Maturity and Treatment Positioning to Support R..:

Shupo, F ; Abrams, K ; Ademi, Z...
Value in Health.  25 (2022)  12 - p. S329 , 2022
Link: https://doi.org/10.1016/..
 
?
7

P.150 The Canadian Medical Student Interest Group in Neuros..:

Arfaie, S ; Mashayekhi, MS ; Farimani, PL...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  49 (2022)  s1 - p. S47-S47 , 2022
Link: https://doi.org/10.1017/..
 
?
8

HPR123 CEE: Brief Overview of Orphan Drug Reimbursement and..:

Jakubowski, S ; Kawalec, P ; Holko, P
Value in Health.  25 (2022)  12 - p. S254 , 2022
Link: https://doi.org/10.1016/..
 
?
9

HPR14 Relationship/Association between Clinical Potential o..:

Jakubowski, S ; Kawalec, P ; Malinowski, K
Value in Health.  25 (2022)  7 - p. S469 , 2022
Link: https://doi.org/10.1016/..
 
?
10

PSY130 - THE RELATIONSHIP BETWEEN DISEASE TYPE AND CONDITIO..:

Malinowski, K. ; Kawalec, P.
Value in Health.  21 (2018)  - p. S458 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Direct Costs Of Inflammatory Bowel Diseases Therapy In Pola..:

Holko, P ; Kawalec, P ; Stawowczyk, E
Value in Health.  20 (2017)  9 - p. A553 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Comparative effectiveness of abatacept, apremilast, secukin..:

Kawalec, P. ; Holko, P. ; Moćko, P..
Rheumatology International.  38 (2017)  2 - p. 189-201 , 2017
Link: https://doi.org/10.1007/..
 
?
13

Indirect Costs Associated with Ulcerative Colitis In Poland:

Kawalec, P ; Stawowczyk, E
Value in Health.  19 (2016)  7 - p. A584 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Indirect Costs Genereted By Absenteeism Associated with Scl..:

Malinowski, K ; Kawalec, P
Value in Health.  19 (2016)  7 - p. A584 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Disease Activity, Quality of Life And Indirect Costs Associ..:

Kawalec, P
Value in Health.  19 (2016)  7 - p. A585 , 2016
Link: https://doi.org/10.1016/..
 
1-15